Arsenic trioxide (As2O3) has been applied to treat acute promyelocytic leukemia (APL) recently according to its proapototic effect on APL cells. In our study, we can observed that, during differentiation of monocyte into DCs in vitro, As2O3 suppressed c-REL, NFκBp50 expression and regulated signal transduction process in DCs. Adding arsenic trioxide down- regulated CD86 expression and decreased IL-12p70, IL-1β, IL-10 secretion, decrease the allogeneic lymphocyte stimulation capacity of DCs, The intracellular IFN-γ expression of T cells stimulated with As2O3 treated DCs, and the capacity of these DCs to promote Th1/Th2 activation were reduced. According to our results, arsenic trioxide may suppress immunologic response via influence on the function of monocyte derived DCs.